BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31155064)

  • 1. Bioorthogonal oncometabolite ligation.
    Briney CA; Najera S; Meier JL
    Methods Enzymol; 2019; 622():431-448. PubMed ID: 31155064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous adaptation of cysteine reactivity to a covalent oncometabolite.
    Perez M; Bak DW; Bergholtz SE; Crooks DR; Arimilli BS; Yang Y; Weerapana E; Linehan WM; Meier JL
    J Biol Chem; 2020 Sep; 295(39):13410-13418. PubMed ID: 32820045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chemoproteomic portrait of the oncometabolite fumarate.
    Kulkarni RA; Bak DW; Wei D; Bergholtz SE; Briney CA; Shrimp JH; Alpsoy A; Thorpe AL; Bavari AE; Crooks DR; Levy M; Florens L; Washburn MP; Frizzell N; Dykhuizen EC; Weerapana E; Linehan WM; Meier JL
    Nat Chem Biol; 2019 Apr; 15(4):391-400. PubMed ID: 30718813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-opting a Bioorthogonal Reaction for Oncometabolite Detection.
    Zengeya TT; Garlick JM; Kulkarni RA; Miley M; Roberts AM; Yang Y; Crooks DR; Sourbier C; Linehan WM; Meier JL
    J Am Chem Soc; 2016 Dec; 138(49):15813-15816. PubMed ID: 27960310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumarate Metabolic Signature for the Detection of Reed Syndrome in Humans.
    Casey RT; McLean MA; Challis BG; McVeigh TP; Warren AY; Mendil L; Houghton R; De Sanctis S; Kosmoliaptsis V; Sandford RN; Gallagher FA; Maher ER
    Clin Cancer Res; 2020 Jan; 26(2):391-396. PubMed ID: 31636096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency.
    Ternette N; Yang M; Laroyia M; Kitagawa M; O'Flaherty L; Wolhulter K; Igarashi K; Saito K; Kato K; Fischer R; Berquand A; Kessler BM; Lappin T; Frizzell N; Soga T; Adam J; Pollard PJ
    Cell Rep; 2013 Mar; 3(3):689-700. PubMed ID: 23499446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC).
    Chan E; Rabban JT; Mak J; Zaloudek C; Garg K
    Am J Surg Pathol; 2019 Sep; 43(9):1170-1179. PubMed ID: 31162287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.
    Ooi A
    Semin Cancer Biol; 2020 Apr; 61():158-166. PubMed ID: 31689495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
    Frezza C; Zheng L; Folger O; Rajagopalan KN; MacKenzie ED; Jerby L; Micaroni M; Chaneton B; Adam J; Hedley A; Kalna G; Tomlinson IP; Pollard PJ; Watson DG; Deberardinis RJ; Shlomi T; Ruppin E; Gottlieb E
    Nature; 2011 Aug; 477(7363):225-8. PubMed ID: 21849978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma.
    Yang Y; Lane AN; Ricketts CJ; Sourbier C; Wei MH; Shuch B; Pike L; Wu M; Rouault TA; Boros LG; Fan TW; Linehan WM
    PLoS One; 2013; 8(8):e72179. PubMed ID: 23967283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes.
    Podkalicka P; Mucha O; Kruczek S; Biela A; Andrysiak K; Stępniewski J; Mikulski M; Gałęzowski M; Sitarz K; Brzózka K; Józkowicz A; Dulak J; Łoboda A
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc.
    Sourbier C; Ricketts CJ; Liao PJ; Matsumoto S; Wei D; Lang M; Railkar R; Yang Y; Wei MH; Agarwal P; Krishna M; Mitchell JB; Trepel JB; Neckers L; Linehan WM
    Sci Rep; 2019 Dec; 9(1):18409. PubMed ID: 31804603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.
    Linehan WM; Rouault TA
    Clin Cancer Res; 2013 Jul; 19(13):3345-52. PubMed ID: 23633457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and "cryptic targets" of transcription factors.
    Ooi A; Furge KA
    Chin J Cancer; 2012 Sep; 31(9):413-20. PubMed ID: 22776233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma.
    Xu Y; Taylor P; Andrade J; Ueberheide B; Shuch B; Glazer PM; Bindra RS; Moran MF; Linehan WM; Neel BG
    Cancer Res; 2018 Dec; 78(23):6539-6548. PubMed ID: 30297534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients.
    Bateman NW; Tarney CM; Abulez T; Soltis AR; Zhou M; Conrads K; Litzi T; Oliver J; Hood B; Driggers P; Viollet C; Dalgard C; Wilkerson M; Catherino W; Hamilton CA; Darcy KM; Casablanca Y; Al-Hendy A; Segars J; Conrads TP; Larry Maxwell G
    Sci Rep; 2021 Apr; 11(1):9371. PubMed ID: 33931688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Warburg effect and renal cancer caused by errs in fumarate hydratase encoding gene.
    Qureshi AS; Ali S
    Pak J Pharm Sci; 2019 Mar; 32(2):743-749. PubMed ID: 31081789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR Spectroscopy for Detecting Fumarate Hydratase Deficiency in Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
    Wu G; Liu G; Wang J; Pan S; Luo Y; Xu Y; Kong W; Sun P; Xu J; Xue W; Zhang J
    Radiology; 2022 Dec; 305(3):631-639. PubMed ID: 35943337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases.
    Pivovarčíková K; Martínek P; Trpkov K; Alaghehbandan R; Magi-Galluzzi C; Mundo EC; Berney D; Suster S; Gill A; Rychlý B; Michalová K; Pitra T; Hora M; Michal M; Hes O
    Cesk Patol; 2019; 55(4):244-249. PubMed ID: 31842557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
    Plevová P; Hladíková A; Tesařová M
    Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.